+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pain Management Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797833
The global pain management market value was USD 4.8 billion in 2022, driven by the increasing prevalence of chronic pain conditions across the globe. The market size is anticipated to grow at a CAGR of 8.7% during the forecast period of 2023-2031 to achieve a value of USD 10.1 billion by 2031.

Pain Management Devices: Introduction

Pain management devices are medical instruments designed to alleviate chronic and acute pain, improving patients' quality of life and reducing reliance on medications. These devices employ various technologies such as electrical stimulation, radiofrequency ablation, ultrasound, and wearable technologies to target and manage different types of pain, including musculoskeletal, neuropathic, and cancer-related pain. Pain management devices offer a non-invasive, non-pharmacological alternative to traditional pain relief methods, minimizing the risk of addiction and side effects associated with pain medications.

Pain Management Devices Market Scenario

The global pain management devices market has experienced substantial growth in recent years, driven by factors such as the increasing prevalence of chronic pain conditions, an aging population, and a growing awareness of the need for effective pain management solutions. Technological advancements, such as the development of smart, connected devices, and the increasing demand for minimally invasive pain management techniques, have further contributed to the market's expansion.

The adoption of pain management devices has been increasing steadily due to factors such as the rising prevalence of chronic pain conditions, an aging population, and growing awareness of the need for effective pain management solutions. Technological advancements, such as the development of smart, connected devices, and the increasing demand for minimally invasive pain management techniques, have further contributed to the market's expansion.

North America: The largest market for pain management devices, driven by factors such as the high prevalence of chronic pain, advanced healthcare infrastructure, and a strong focus on the development and adoption of innovative pain management solutions.

Europe: The second-largest market, with increasing demand for pain management devices due to a growing awareness of the importance of effective pain management and supportive regulatory frameworks.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic pain conditions, and growing investments in healthcare infrastructure.

Market Segments

Market Breakup by Type

Neurostimulation Devices

  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Spinal Cord Stimulation (SCS) Devices

Ablation Devices

  • RF Ablation Devices
  • Cryoablation Devices

Analgesic Infusion Pump

  • Internal
  • External

Market Breakup by Mode of Purchase

  • OTC
  • Prescription Based

Market by Application

  • Neuropathic Pain
  • Cancer Pain
  • Facial Pain and Migraine
  • Musculoskeletal Pain
  • Others

Market Breakup by Application

POC

  • Glucose Monitoring
  • Cardiac Marker
  • Infectious Disease Detection
  • Coagulation Monitoring
  • Pregnancy Testing
  • Blood Gas and Electrolyte Detection
  • Detection of Tumor or Cancer Marker
  • Urinalysis Testing
  • Cholesterol Testing

Home Diagnostic

  • Glucose Monitoring
  • Pregnancy Testing
  • Cholesterol Testing
  • Research Labs
  • Environmental Monitoring
  • Food and Beverages
  • Biodefence

Market Breakup by End User

  • Home Healthcare Diagnostics
  • POC Testing
  • Food Industry
  • Research Laboratories
  • Security and Biodefence

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Pain Management Devices Market

Some key trends of the market are as follows:
  • Wearable pain management devices: The development and adoption of wearable devices, such as transcutaneous electrical nerve stimulation (TENS) units and smart pain-relief patches, are gaining traction due to their ease of use, portability, and convenience
  • Integration of digital technologies: The incorporation of digital technologies, such as mobile apps and remote monitoring, is improving the delivery, tracking, and personalization of pain management solutions
  • Focus on non-opioid pain relief: With the growing opioid crisis, there is an increased emphasis on non-opioid alternatives for pain management, leading to the development of innovative pain management devices

Pain Management Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc
  • Medtronic Plc
  • Braun Melsungen AG
  • Baxter
  • Nevro Corp
  • Enovis
  • OMRON Healthcare, Inc
  • ICU Medical, Inc
  • Stryker Corporation
  • Stimwave LLC

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pain Management Devices Overview
3.1 Global Pain Management Devices Market Historical Value (2016-2022)
3.2 Global Pain Management Devices Market Forecast Value (2023-2031)
4 Global Pain Management Devices Landscape
4.1 Global Pain Management Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pain Management Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Pain Management Devices Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pain Management Devices Market Segmentation
6.1 Global Pain Management Devices Market by Type
6.1.1 Market Overview
6.1.2 Neurostimulation Devices
6.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
6.1.2.2 Spinal Cord Stimulation (SCS) Devices
6.1.3 Ablation Devices
6.1.3.1 RF Ablation Devices
6.1.3.2 Cryoablation Devices
6.1.4 Analgesic Infusion Pump
6.1.4.1 Internal
6.1.4.2 External
6.2 Global Pain Management Devices Market by Mode of Purchase
6.2.1 Market Overview
6.2.2 OTC
6.2.3 Prescription Based
6.3 Global Pain Management Devices Market by Application
6.3.1 Market Overview
6.3.2 Neuropathic Pain
6.3.3 Cancer Pain
6.3.4 Facial Pain and Migraine
6.3.5 Musculoskeletal Pain
6.3.6 Others
6.4 Global Pain Management Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Home healthcare
6.4.5 Ambulatory Surgical Centers
6.4.6 Laboratories & Research facilities
6.5 Global Pain Management Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Pain Management Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pain Management Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pain Management Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pain Management Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pain Management Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 B. Braun Melsungen AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Johnson & Johnson Services, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic Plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Braun Melsungen AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Baxter
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nevro Corp.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Enovis
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 OMRON Healthcare, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ICU Medical, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Stryker Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Stimwave LLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Pain Management Devices Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Braun Melsungen AG
  • Baxter
  • Nevro Corp.
  • Enovis
  • Omron Healthcare, Inc.
  • Icu Medical, Inc.
  • Stryker Corporation
  • Stimwave LLC

Methodology

Loading
LOADING...

Table Information